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Summary
Background: Function of the hypothalamus—pituitary—adrenal (HPA) axis has been associated
with several somatic and psychiatric health problems. The amount of free cortisol excreted in the
urine during 24 h (24-h UFC) has often been used as a proxy for HPA-axis function. Reference
values for 24-h UFC and their stability in the short and long term, as well as sources of variability,
are largely lacking.
Methods: This study was performed in a general population cohort. Participants collected 24-h
UFC on two consecutive days (T1), and repeated this collection approximately 2 years later (T2).
Cortisol in urine was measured using LC—MS/MS. Height and weight were measured at the
research facilities; glomerular filtration rate was estimated using creatinine clearance. Psycho-
logical distress (General Health Questionnaire), smoking, alcohol use and exercise weremeasured
by means of questionnaires.* Corresponding author. Tel.: +31 50 361 4812; fax: +31 50 361 9722.
E-mail address: j.g.m.rosmalen@umcg.nl (J.G.M. Rosmalen).
http://dx.doi.org/10.1016/j.psyneuen.2014.04.018
0306-4530/# 2014 Elsevier Ltd. All rights reserved.
Results: 24-h UFC stability on a day-to-day basis was 0.69 (T1, N = 1192) and 0.72 (T2, N = 963)
(both p < 0.001). Long-term stability as indicated by correlation between 2-day averages of T1
and T2 was 0.60 (N = 972, p < 0.001). Multivariable linear regression analysis revealed that 24-h
UFC was predicted by urine volume (standardized beta 0.282 (T1, N = 1556) and 0.276 (T2,
N = 1244); both p < 0.001) and glomerular filtration rate (standardized beta 0.137 (T1) and 0.179
(T2); both p < 0.001), while also sex explained a small part (standardized beta for female sex
0.057 (T1) and 0.080 (T2); both p < 0.05).
Conclusion: 24-h UFC is moderately stable both in the short and the long term. The effects of
urine volume and glomerular filtration rate on 24-h UFC are much stronger than those of sex.
# 2014 Elsevier Ltd. All rights reserved.
Stability and sources of variability in 24 h urinary cortisol in population cohorts 111. Introduction
HPA-axis activity is investigated as an etiological factor in a
variety of diseases, including the metabolic syndrome,
depression, and functional somatic syndromes. The assess-
ment of HPA-axis activity in epidemiological studies is usually
done by measuring its end-product cortisol. Under basal
conditions, cortisol is predominantly bound to cortisol-bind-
ing globulin (also named transcortin), while a small amount is
bound to albumin with weak affinity. The fraction of cortisol
in the plasma is filtered by the kidney, in which the vast
majority is reabsorbed by the proximal tubule. A small
fraction of unconjugated cortisol is excreted unchanged
in urine.
The amount of (free) cortisol excreted in urine during 24 h
(24-h UFC) has often been used as a proxy for HPA-axis
function (Heitkemper et al., 1996; Seeman et al., 1997;
Griep et al., 1998; Oldehinkel et al., 2001; Cleare et al.,
2001; Bierer et al., 2006; Chamarthi et al., 2007; Penninx
et al., 2007; Simeon et al., 2007; Tak et al., 2009). Measure-
ment of 24-h UFC excretion has the advantage of being
unaffected by short-term fluctuations in cortisol and by
varying plasma protein binding capacities (Remer et al.,
2008). 24-h UFC is thought to reflect overall daily cortisol
production and is, compared to serial blood sampling, rela-
tively easy to collect in a large study population. An impor-
tant advantage of this method is its reliability (Kushnir et al.,
2003).
Several studies found associations between 24-h UFC and
somatic or psychiatric pathology (Oldehinkel et al., 2001;
Vogelzangs et al., 2010; Tak et al., 2011). When interpreting
these findings, one should realize that these types of analyses
not only assume that there is variation in 24-h UFC secretion
between individuals, but also that individual 24-h UFC secre-
tion is a relatively stable trait over time within individuals. It
is questionable whether this latter assumption holds true,
since the long- and short-term stability of 24-h UFC have
rarely been studied. Moreover, the sources of variation in 24-
h UFC are largely unknown.
One potential determinant of the total 24-h UFC is urine
volume. Previous studies on the relation between urine
volume and the total urinary free cortisol excretion are
equivocal, with some studies suggesting a positive relation
whereas others found no relation (Fenske, 2006). A potential
explanation for these inconsistencies is that urinary free
cortisol values that have been determined by some of the
assays may represent the sum of cortisol and cortisone(Fenske, 2004). One experimental study found an elevation
of urinary free cortisol and urinary free cortisone excretion
after water loading, albeit with a more prominent stimula-
tion of urinary free cortisone than free cortisol excretion
(Fenske, 2006). This was suggested to be the consequence of
augmented formation of cortisone from cortisol, the latter
escaping from metabolism or reabsorption in the proximal
tubule. Previous associations between urine volume and 24-h
UFC might thus be largely explained by cross-reactivity, and
it remains unknown whether a true association between
urine volume and 24-h UFC exists.
Another source of variation is renal function. Since plasma
free cortisol is filtered through the glomeruli with partial
tubular reabsorption, the amount of free cortisol appearing
in the urine is theoretically dependent on the glomerular
filtration rate. Indeed, in a previous study of the relationship
between glomerular filtration rate and urinary cortisol excre-
tion it was shown that patients with moderate and especially
severe renal impairment had significantly lower 24-h UFC
excretion rates than those with no or mild renal impairment
(Chan et al., 2004). It is currently unclear whether normal
variation in renal function is associated with 24-h UFC.
Sex (Raven and Taylor, 1996), age (VanCauter et al., 1996),
smoking (Badrick et al., 2007), alcohol consumption (Thayer
et al., 2006), exercise frequency (Luger et al., 1987), stress-
ful events (Schubert et al., 2012) and body mass index (BMI)
(Ukkola et al., 2001) may also be responsible for variance in
24-h UFC excretion.
Thus, although 24 h urinary cortisol has been used in
several studies, several methodological questions remain
that hamper the interpretation of the results. The aims of
this study are twofold. First, we want to calculate the short-
(two days) and long-term (two years) stability of 24-h UFC
excretion. Second, we want to identify major sources of
variability in 24-h UFC.
We use a large cohort study, in which urinary free cortisol
was measured by liquid chromatography—tandem mass spec-
trometry (LC—MS/MS) analysis. Use of LC—MS/MS is recom-
mended because this method offers advantages over
immunoassays; the LC—MS/MS method is free of interfer-
ences from cortisol metabolites and conjugates and also
eliminates drug interferences (Taylor et al., 2002). This is
particularly important in this field of research, since reported
cortisol levels vary widely between different laboratories,
which is likely to be caused by the use of methods which may
not distinguish between cortisol and its metabolites (Pearson
Murphy, 1999; Fenske, 2004).
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2.1. Population
Our investigation was performed in a cohort derived from the
Prevention of REnal and Vascular ENd stage Disease (PRE-
VEND) study, a major population-based cohort study inves-
tigating microalbuminuria as a risk factor for renal and
cardiovascular disease. The recruitment of participants for
PREVEND has been extensively described elsewhere (Pinto-
Sietsma et al., 2000). All inhabitants of the city of Groningen,
the Netherlands, between the ages of 28 and 75 years (85,421
subjects) were asked to send in amorning urine sample and to
fill out a short questionnaire on demographics and cardio-
vascular history. A total of 40,856 subjects (47.8%)
responded. After exclusion of subjects with insulin depen-
dent diabetes mellitus and pregnant women, all subjects
with an elevated urinary albumin concentration of 10 mg/l
(N = 7768) together with a randomly selected control group
with a urinary albumin concentration of <10 mg/l (N = 3395)
were invited for further investigations (total N = 11,163).
Finally, 8592 subjects completed the total screening pro-
gram, rendering the PREVEND study cohort at T0 with a ratio
of albuminuria-negative to albuminuria-positive subjects of
0.43. Because the PREVEND study population was enriched
for albuminuria this oversampling for albuminuria was rec-
tified in the current substudy. Albuminuria-negative partici-
pants were combined with a random sample of albuminuria-
positive participants until a population-representative ratio
of 3.08 was achieved. This resulted in a cohort of 2880
participants for whom at least one cortisol value was avail-
able at T1, for which data were collected between April 2001
and December 2003. These subjects were re-assessed
(N = 2440, 84.7%) at T2, for which data were collected
between December 2003 and October 2006. The median
follow up period was 2.23 years (Inter Quartile Range (IQR)
2.11—2.43 years). All subjects gave written consent to par-
ticipate in the study, which was approved by the local
medical ethics committee.
2.2. HPA-axis function
Participants were asked to collect urine samples in a poly-
propylene container on two consecutive days at T1 and T2
(resulting in four urine collections for each participant). They
were instructed to urinate into the container during the 24 h
collection period, starting at 22:00 h, and store the sample in
the fridge until delivery to the laboratory. Presumably incom-
pliant subjects were excluded based on the following for-
mula: (urinary creatinine [mmol/d]  113)/(21  body
weight [kg]) of <0.7 (Knuiman et al., 1986), which proved
to be the method of choice in a comparative analysis of
exclusion strategies (Murakami et al., 2008). Numbers
excluded were 733 (day 1) and 648 (day 2) for T1 (with an
overlap of 439), and 690 (day 1) and 599 (day 2) for T2 (with
an overlap of 428). Urinary free cortisol was measured by
liquid chromatography—tandem mass spectrometry (LC—MS/
MS) analysis (Taylor et al., 2002). The lower detection limit of
the assay was 0.3 nmol/l. At low, middle, and high concen-
trations, intra-assay variation ranged from 1.3% to 2.4% while
inter-assay variation ranged from 3.8% to 7.8%.2.3. Medication use
Information on drug use was obtained from the IADB.nl,
which contains dispensing information from 55 community
pharmacies in the Netherlands, covering on average 500,000
persons annually (www.IADB.nl) (Visser et al., 2013). The
database’s pharmacy information includes, among others,
name of the drug, anatomic—therapeutic—chemical (ATC)
classification and date of prescription. With the exception of
over-the-counter drugs and in-hospital prescriptions, all pre-
scriptions are included regardless of prescriber, insurance, or
reimbursement status. Medication records of patients are
virtually complete because of high patient pharmacy com-
mitment in the Netherlands (Monster et al., 2002). We
extracted information on drug prescriptions from 100 days
prior until 100 days after the date of the visit to our research
facilities. We excluded participants using inhalation, local,
gastrointestinal, or systemic glucocorticosteroids from the
analyses (N = 550 for T1; N = 414 for T2; with an overlap of
218 participants using glucocorticoids at both T1 and T2).
2.4. Demographic and lifestyle factors
Sex, age, smoking, alcohol consumption, and exercise fre-
quency were assessed by written self-report. Smoking was
divided into current, past (>1 year), and never smoker.
Exercise was indicated by the frequency of exercise
(0 = not/hardly, 1 = once per week, 2 = twice or more per
week). Alcohol consumption was divided based on the cur-
rent mean number of alcoholic beverages into no alcohol use,
3 or less units per day, more than 3 units per day. One unit is
equal to one serving of alcohol. Height and weight were
measured and body mass index was calculated as the ratio
between weight and the square of height (kg/m2).
2.5. Psychological distress
Psychological distress was assessed using the Dutch version of
the 12-item General Health Questionnaire (GHQ-12) (Koeter,
1992). Psychological distress scores were obtained by sum-
ming the Likert scores (0—1—2—3) on the 12 items. Missing
values were imputed using Corrected Item Mean substitution
if at least 50% of the items were completed (Huisman, 2000).
2.6. Renal function
Renal function (Chan et al., 2004) and urine volume (Mericq
and Cutler, 1998) may be responsible for variance in 24-h UFC
excretion. Glomerular filtration rate (GFR) was estimated
using creatinine clearance ((1000/1440) * mean((urine
volume day 1 * urinary creatinine concentration day 1),
(urine volume day 2 * urinary creatinine concentration day
2))/serum creatinine concentration). Creatinine clearance is
a good alternative for true GFR if information on 24 h urinary
creatinine excretion is available (Traynor et al., 2006). The
potential influence on serum creatinine levels of factors like
meat consumption and exercise are taken into account by
dividing serum creatinine by urinary creatinine excretion in
the formula for calculating creatinine clearance (Traynor
et al., 2006). As a result of tubular secretion of creatinine,
creatinine clearance tends to slightly overestimate true
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error of fairly stable magnitude over the range of renal
function, until advanced renal failure is reached (Traynor
et al., 2006). Creatinine was assessed as described previously
(Verhave et al., 2004). Blood sampling was performed in the
fasting state, in the morning after the second 24 h urine
collection.
2.7. Statistical analysis
All analyses were performed using IBM SPSS Statistics version
20. First, the 2-day average of total 24-h UFC was calculated
based on compliant days (if only one compliant day was
available, this value replaced the two-day average). To
ensure normal distribution for parametric analyses, all cor-
tisol values were log-transformed after which outliers which
differed more than 3SD from the mean were removed (N = 17
(day 1), 17 (day 2), and 13 (2-day average) for T1; N = 15
(day1), 9 (day2), and 15 (2-day average) for T2). Second, we
examined short and long term stability by calculating PearsonTable 1 Descriptives of the study population at T1 and T2.
BMI: body mass index; GFR: glomular filtration rate according
to creatinine clearance; 24-h UFC: 24-h urinary free cortisol;
IQ R: inter quartile range; GHQ-12: 12-item General Health
Questionnaire.
T1 T2
Age mean (SD) 50.5 (10.9) 52.7 (10.6)
Sex (% female) 45.4% 41.7%
Smoking (%)
Current 31.6% 30.8%
Past (>1 year) 40.9% 45.4%
Never 27.5% 23.7%
Alcohol (%)
No alcohol use 19.2% 19.8%
3 or less units
per day
76.6% 76.3%
More than 3
units per day
4.2% 4.0%
Exercise frequency (%)
Not/hardly 53.2% 51.8%
Once/week 26.8% 25.0%
Twice or
more/week
20.0% 23.2%
BMI (kg/m2)
mean (SD)
25.7 (3.6) 25.6 (3.5)
GFR (ml/min)
mean (SD)
110.4 (22.4) 103.3 (21.0)
2-day average
of urine
volume (SD) (l)
1.79 (0.58) 1.84 (0.59)
24-h UFC median
(IQ range)
(nmol/24 h)
70.8 (49.6—99.7) 72.2 (49.8—99.8)
Psychological
distress
(GHQ-12)
mean (SD)
11.1 (5.5) 10.9 (5.3)r for the 24-h UFC over two days, and for the 2-day average of
24-h UFC over two years. Finally, we investigated sources of
variability by performing multivariable regressions. Multi-
variable linear regression analyses were performed sepa-
rately for T1 and T2 to study independent effects of
predictors on the 2-day average of 24-h UFC and reproduci-
bility of results.
3. Results
3.1. Study population
Table 1 shows the characteristics of our study population at
the two visits (T1 and T2).
3.2. Short-term and long-term stability of
cortisol values
24-h UFC values were relatively stable over two days and over
two years. The correlation between 24-h UFC on day 1 and 2
was for T1 0.69 (N = 1192, p < 0.001) and for T2 0.72
(N = 963, p < 0.001). The correlation between T1 and T2
for the two-day average of 24-h UFC was 0.60 (N = 972,
p < 0.001). To study the influence of follow up duration,
we calculated T1—T2 correlations for the two-day average
of 24-h UFC separately for participants with a follow up
duration below and above the median. As expected, shorter
follow up durations were associated with higher stability
(Pearson r = 0.63, N = 465, p < 0.001 for follow up durations
below the median, and Pearson r = 0.57, N = 483, p < 0.001
for follow up durations above the median).
3.3. Sources of variability: multivariable
associations
Table 2 summarizes the multivariable models predicting the
average 24-h UFC values at T1 and T2. Consistent relation-
ships with 24-h UFC were found at both T1 and T2 for sexTable 2 Multivariable models predicting 24-h urinary free
cortisol. Standardized betas are provided. GFR: estimated
glomerular filtration rate according to creatinine clearance;
BMI: body mass index; GHQ-12: 12-item General Health Ques-
tionnaire.
T1 (N = 1556) T2 (N = 1244)
Female sex 0.057 * 0.080 *
Age 0.035 0.040
Urine volume (l) 0.282 ** 0.276 **
GFR (ml/min) 0.137 ** 0.179 **
BMI (kg/m2) 0.065 * 0.047
Exercise frequency 0.014 0.050
Smoking 0.054 * 0.044
Alcohol use 0.020 0.036
Psychological distress (GHQ-12) 0.009 0.022
Adjusted R square 0.100 0.115
* p < 0.05.
** p < 0.001.
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tive). A lack of association was consistently found for age,
exercise frequency, alcohol use, and psychological distress.
Equivocal results were found for BMI and smoking, which both
had a small but significant effect on 24-h UFC at T1 which
could not be replicated at T2.4. Discussion
This study shows that 24-h UFC is moderately stable in both
the short (day to day) and the long term (two years). The
most important sources of variability identified include urine
volume and creatinine clearance, while also sex explained a
small part of the cortisol variability.
To the best of our knowledge, we present the most
extensive analyses of 24-h UFC in the literature. Strengths
of this study are the large sample and the longitudinal
dataset. The two measurement waves enable us to test
reproducibility of the results in the same population using
the same method. The repeated measurements also enable
us to estimate long-term stability of 24-h UFC, while at the
same time decreasing the risk of a chance finding while
studying sources of variability. Another strength of our study
is the use of LC—MS/MS enabling us to distinguish between
urinary cortisol and cortisone, thereby avoiding the problem
that urinary free cortisol values that have been determined
by competitive binding assays may represent the sum of
cortisol and cortisone (Fenske, 2004).
A limitation of our study is that additionally assessing the
major urinary cortisol metabolites would have provided a
more precise estimation of the cortisol secreted by the
adrenal gland (Remer et al., 2008). Furthermore, 24-h UFC
is sensitive to urine collection errors. We corrected for this by
excluding presumably incompliant individuals (Knuiman
et al., 1986), which proved to be the method of choice in
a comparative analysis of exclusion strategies (Murakami
et al., 2008). Excluding presumable non-compliant subjects
is preferable over analyzing cortisol concentration in urine
per unit of creatinine, since the latter does not take into
account the point of the circadian rhythm (e.g. 08:00 h vs
20:00 h) at which the subject missed a urine collection, and
the exact time point substantially influences UFC levels.
Nevertheless, this led to the exclusion of a relatively large
number of participants, which might have influenced the
results if non-compliance was related to the amount of
stressors encountered during the day. The final dataset might
thus be composed of individuals collecting urine on days with
low levels of stress, which would probably inflate the stability
of the 24-h UFC, and underestimate its association with
psychological distress.
Our results point to a reasonable day-to-day variation in
24-h UFC values. This has implications for the effect sizes
that might be expected when associating cortisol to health
problems. It also means that it is important to only use large
cohorts for such studies in order to obtain sufficient power.
Our data reveal some interesting sources of variability in
cortisol values.
We found urine volume to be positively associated with
total urinary free cortisol excretion. Previous studies finding
a positive correlation between 24-h UFC and urine volume
were not able to exclude the possibility that this increase in24-h UFCwith increasing urine volumewas actually reflecting
an increase in cortisone which was detected by the compe-
titive binding assays used (Fenske, 2004). Our results prove
the existence of a positive association between urine volume
and 24-h UFC independent of increased cortisone formation.
Thus, our study using LC—MS/MS provides an answer to this
controversy in the literature.
Another important source of variability is GFR, which is
positively associated with 24-h UFC and cortisol concentra-
tion. Our results are in line with a previous study showing that
patients with moderate and especially severe renal impair-
ment had significantly lower 24-h UFC rates than those with
no or mild renal impairment (Chan et al., 2004). We show for
the first time that similar associations can be found in the
general population. Consistent unique effects on 24-h UFC
were also found for sex, although the effect was small.
The question arises for which purposes urinary cortisol
would be interesting. A disadvantage of using 24-h UFC as a
measure of HPA-axis function is that it does not provide any
information about the diurnal fluctuations in cortisol secre-
tion, in contrast to serial salivary samples. Salivary cortisol
could be used as an alternative, but is very sensitive to the
exact timing of sampling. 24-h UFC has been criticized as a
marker of cortisol secretion, even in mild forms of Cushings
disease (Alexandraki and Grossman, 2011). Only about 2—3%
of the cortisol produced per day can be detected as uncon-
jugated cortisol in urine (Gatti et al., 2009). A by far greater
percentage of the excreted cortisol is metabolized before it
shows up in urine (beside the fraction that is excreted via
colon and skin). Thus, even small changes in the complex
metabolic process could easily halve, double or triple the
assessed urinary cortisol level. This implies that even intrain-
dividual stability over time of 24-h UFC may predominantly
reflect the stability of the metabolic processes in liver and
kidney and not the function of interest, i.e. adrenocortical
activity. In addition, there are serious doubts about whether
free cortisol is the only biologically active fraction; other
candidates are cortisol which is only loosely bound to albu-
min, and the corticosterone—CBG complex (Levine et al.,
2007). However, studies do suggest that urinary cortisol
reflects blood levels, as shown by a strong association
between plasma and excreted cortisol in an early study
(Beisel et al., 1964) and high intraclass correlation between
24-h UFC and salivary and serum cortisol in a more recent
study (Neary et al., 2002). The use of urinary cortisol for
psychobiological approaches is supported by a single-subject
study in which 24-h UFC was assessed for 63 days, which
revealed that stressful incidents were reflected in subse-
quent changes in urinary cortisol (Schubert et al., 2012).
Another study showed that urinary cortisol increases under
influence of stress associated with a parachute jump (Plenis
et al., 2011). As mentioned, several interesting associations
between psychiatric and somatic health problems and urin-
ary cortisol have been published previously (Oldehinkel
et al., 2001; Vogelzangs et al., 2010; Tak et al., 2011). We
did not show any associations with psychological distress, as
assessed with the GHQ-12. This questionnaire assesses psy-
chological distress in the previous weeks. It remains possible
that the day of sampling was not representative for the levels
of psychological distress in the last weeks, which might
explain the lack of association between 24-h UFC and psy-
chological distress.
Stability and sources of variability in 24 h urinary cortisol in population cohorts 15We conclude that 24-h UFC is a suitable measure to study
HPA-axis activity in epidemiological cohorts. When interpret-
ing the data, the effects of urine volume and glomerular
filtration rate on 24-h UFC could be taken into account.
Studies that collect time series of 24 h UFC within an indi-
vidual over several weeks would be interesting to further
unravel cortisol stability, and to study whether this variability
differs between individuals. It remains important to use
assays that are not influenced by cross-reactivity, and to
ensure a rather strict and exact urine collection. The useful-
ness in the study of psychobiological research, and the exact
meaning of the measure, deserve further study.
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